Allergy Medication

Trusted pharma products in Allergy Medication

Olopatadine

Strength: 0.1%, 0.2% & 0.7%

Form: Eye Drops

Reference Brands: Patanol(US & EU); Pataday(US); Opatanol(EU)

View Details Get Enquiry

Olopatadine Eye Drops

Strength: 0.1% w/v, 0.2%, 0.7%

Form: Drop

Reference Brands: Patanol (USA), Opatanol (EU)

View Details Get Enquiry

Oxymetazoline

Strength: 0.025%, 0.05%, 0.1%

Form: Nasal Drops

Reference Brands: Afrin®, Dristan®, Zicam®(US); Nasivin®, Vicks Sinex®(EU)

View Details Get Enquiry

Oxymetazoline Nasal Drops

Strength: 0.1% w/v, 0.05%

Form: Drop

Reference Brands: Afrin (USA), Nasivin (EU)

View Details Get Enquiry

Pheniramine Maleate

Strength: 22.75 mg/mL (2 mL ampoule)

Form: Injection

Reference Brands: Avil® Injection(EU only)

View Details Get Enquiry

Pheniramine Maleate Injection

Strength: 22.75 mg/ml, 45.5 mg/2 ml

Form: Injection

Reference Brands:

View Details Get Enquiry

Phenylephrine + Chlorpheniramine Caplet

Strength: Phenylephrine HCl(10 mg); Chlorpheniramine Maleate(4 mg)

Form: Caplet

Reference Brands: Dimetapp® Cold & Allergy(US); Actifed®, Sinutab®, or Coldrex®(EU)

View Details Get Enquiry

Phenylephrine Chlorpheniramine

Strength: Phenylephrine(2.5 mg) + Chlorpheniramine(1 mg)per 5 mL

Form: Syrup

Reference Brands: Dimetapp Cold & Allergy(US); Chlorpe-P(EU)

View Details Get Enquiry

Phenylephrine Chlorpheniramine Drops

Strength: 5mg+2mg,

Form: Drops

Reference Brands:

View Details Get Enquiry

Promethazine

Strength: 6.25 mg/5 mL(US) ; 5 mg/5 mL(EU)

Form: Oral Syrup

Reference Brands: Phenergan(US); Phenergan Elixir, Sominex(EU)

View Details Get Enquiry

Promethazine

Strength: Rectal Suppo. & Tablets(12.5 mg, 25 mg, 50 mg); Injection(25 mg/mL, 50 mg/mL)

Form: Tablet, Injection & Rectal suppositories

Reference Brands: Phenergan, Promethegan, Phenergan Injection(US & EU)

View Details Get Enquiry

Promethazine Hydrochloride Injection

Strength: 25mg/ml

Form: Injection

Reference Brands: Phenergan Injection (USA)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.